PMC:7736111 / 101214-101529 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2359","span":{"begin":72,"end":79},"obj":"Species"},{"id":"2360","span":{"begin":284,"end":292},"obj":"Species"}],"attributes":[{"id":"A2359","pred":"tao:has_database_id","subj":"2359","obj":"Tax:9606"},{"id":"A2360","pred":"tao:has_database_id","subj":"2360","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Thus, pre-caution should be taken while using this approach, i.e., if a patient already has adequate virus-specific antibodies or presence of cross-reactive and auto-antibodies, plasma therapy may do more harm than good, which may be the reason with non-responsiveness of CPT in some patients (Nagoba et al., 2020)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T596","span":{"begin":0,"end":315},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Thus, pre-caution should be taken while using this approach, i.e., if a patient already has adequate virus-specific antibodies or presence of cross-reactive and auto-antibodies, plasma therapy may do more harm than good, which may be the reason with non-responsiveness of CPT in some patients (Nagoba et al., 2020)."}